Orient Pharma Co., Ltd. announced earnings results for the half year ended June 30, 2020. For the half year, the company announced sales was TWD 167.253 million compared to TWD 132.821 million a year ago. Operating loss was TWD 74.873 million compared to TWD 110.967 million a year ago. Net loss was TWD 59.939 million compared to TWD 84.121 million a year ago. Basic loss per share was TWD 0.38 compared to TWD 0.54 a year ago.